Figure 6

The expression of LAMC2, CTSE and SLC6A14 in TCGA datasets. (A) The expression of LAMC2, CTSE and SLC6A14 was distinctly increased in PC specimens compared with non-tumor specimens from TCGA datasets. (B) The diagnostic value of LAMC2, CTSE and SLC6A14 was confirmed. (C) Pan-cancer assays of LAMC2, CTSE and SLC6A1, which exhibited a dysregulated level in several types of tumors.